CTMX Financials

CytomX Therapeutics Inc - Financial statements & key metrics

Stock Price

$0.00

Market Cap

$653.11M

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$138.10M

Gross Profit

Operating Income

Net Income

$31.87M

EPS (Diluted)

Balance Sheet Highlights

Total Assets

$120.53M

Total Liabilities

$120.99M

Shareholders Equity

Cash & Equivalents

$38.05M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-86.23M

CapEx

Free Cash Flow

Profitability Metrics

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is CTMX revenue?

CTMX's most recent quarterly revenue was $138.10M. Annual revenue can be calculated by summing the four most recent quarters.

Is CTMX profitable?

CTMX reported a profit of $31.87M in the most recent quarter.

What is CTMX market cap?

CTMX has a market capitalization of $653.11M, making it a small-cap stock.

Does CTMX have debt?

View CTMX's balance sheet for debt information.

What is CTMX cash flow?

Cash flow data is available in the full financial statements.